SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹75 Cr | ₹59 Cr | ₹20 Cr | ₹11 Cr | ₹12 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹75 Cr |
Mar2023 | ₹59 Cr |
Mar2022 | ₹20 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹12 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹75 Cr | 26.75 | |
Mar2023 | ₹59 Cr | 187.19 | |
Mar2022 | ₹20 Cr | 82.98 | |
Mar2021 | ₹11 Cr | -5.49 | |
Mar2020 | ₹12 Cr | - |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹1,395.6 Cr | 8.2% | 46.3% | 395.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | 8.2% |
46.3% |
395.9% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses